Importantly, compared with their Zbp1+/+ littermates, Zbp1-/- mice presented a significantly lower pulmonary bacterial burden and decreased lung injury (Figs 6D and S8H), similar to the effects observed in mice treated with the dsRNA antibody during pulmonary E. coli infection. Here, ZBP1 is linked to escherichia coli infection.